MACKEY CATHERINE J — SEC Form 4 filings
SEC reporting owner CIK 1645330. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-31 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Avid Bioservices, Inc. (CDMO) | Director | 2 | — | — | 8 |
| IDEAYA Biosciences, Inc. (IDYA) | Director | 3 | — | — | 3 |
| Voyager Therapeutics, Inc. (VYGR) | Director | 3 | — | — | 3 |
Form 4 filings — MACKEY CATHERINE J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Avid Bioservices, Inc. (CDMO) | Disposition to issuer (D): 43,379 · Disposition to issuer (D): 32,100 (derivative) · Disposition to issuer (D): 19,675 (derivative) · Disposition to issuer (D): 10,030 (derivative) · Disposition to issuer (D): 8,147 (derivative) | EDGAR |
| 2024-12-17 | 4 | Avid Bioservices, Inc. (CDMO) | Option exercise (M): 26,756 · Option exercise (M): 26,756 (derivative) @ $0 · Grant/award (A): 8,147 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | IDEAYA Biosciences, Inc. (IDYA) | Grant/award (A): 16,200 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1645330 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →